Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Brimonidine 3mg/g gel |
| BNF code | 1306030A0AAAAAA |
| Virtual Therapeutic Moiety | Brimonidine |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Date of name applicability | 10 Jun 2014 |
| Previous name | Generic Mirvaso gel |
| Basis of previous name | rINN - Recommended International Non-proprietary |
| Reason for name change | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Brimonidine tartrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372547000 |
| Strength value numerator | 3.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | gram |
| Ontology Drug Form & Route | |
| Form & Route | gel.cutaneous |
| Dose Form | |
| Formulation | Cutaneous gel |
| Drug Route | |
| Route | Cutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Mirvaso 3mg/g gel (Galderma (UK) Ltd) | |
| Virtual Medicinal Product Packs | |
| Brimonidine 3mg/g gel 30 gram | |
dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.